The prevalence of pulmonary hypertension assessed using the pulmonary vein-to-right pulmonary artery ratio and its association with survival in West Highland white terriers with canine idiopathic pulmonary fibrosis.
Animals
Case-Control Studies
Dog Diseases
/ diagnostic imaging
Dogs
Echocardiography
/ veterinary
Genetic Predisposition to Disease
Hypertension, Pulmonary
/ diagnostic imaging
Idiopathic Pulmonary Fibrosis
/ veterinary
Prevalence
Pulmonary Artery
/ diagnostic imaging
Pulmonary Veins
/ diagnostic imaging
Sildenafil Citrate
/ therapeutic use
Treatment Outcome
Vasodilator Agents
/ therapeutic use
Cardiac disease
Dog
Echocardiography
Pulmonary arterial pressure
Tricuspid regurgitation
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
23 Apr 2021
23 Apr 2021
Historique:
received:
24
09
2020
accepted:
14
04
2021
entrez:
24
4
2021
pubmed:
25
4
2021
medline:
31
8
2021
Statut:
epublish
Résumé
Pulmonary hypertension (PH) is a known co-morbidity in West Highland white terriers (WHWTs) affected with canine idiopathic pulmonary fibrosis (CIPF). The pulmonary vein-to-right pulmonary artery ratio (PV/PA) has recently been described for the detection of pre-capillary PH in dogs. The objective of the present study was to estimate the prevalence of PH at diagnostic, in WHWTs affected with CIPF, by using PV/PA, in comparison with a group of healthy breed-matched controls (CTRLs). Additional study objective was to explore whether the presence of PH at initial diagnosis of CIPF impacted survival time in dogs treated with sildenafil. Twenty-five client-owned WHWTs presented with CIPF and 19 CTRLs were included in the study. PV/PA in either two-dimensional mode (2D) or time-motion mode or both were measured from cineloops in each dog. Dogs were classified according to PV/PA value into non/mild PH (PV/PA measured in 2D ≥ 0.7) or moderate/severe PH (PV/PA < 0.7). Survival data of WHWTs affected with CIPF were extracted from medical record to assess association between presence of PH at diagnosis and outcome. 60 % overall prevalence for moderate/severe PH was estimated in this cohort of WHWTs presented with CIPF vs. 5 % in CTRLS (P = 0.0002). The presence of moderate/severe PH at initial presentation was not associated with survival. Results of the present study confirm a high prevalence of PH at diagnosis in WHWTs affected with CIPF and highlight the utility of PV/PA as a non-invasive surrogate for assessment of PH in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary hypertension (PH) is a known co-morbidity in West Highland white terriers (WHWTs) affected with canine idiopathic pulmonary fibrosis (CIPF). The pulmonary vein-to-right pulmonary artery ratio (PV/PA) has recently been described for the detection of pre-capillary PH in dogs. The objective of the present study was to estimate the prevalence of PH at diagnostic, in WHWTs affected with CIPF, by using PV/PA, in comparison with a group of healthy breed-matched controls (CTRLs). Additional study objective was to explore whether the presence of PH at initial diagnosis of CIPF impacted survival time in dogs treated with sildenafil.
RESULTS
RESULTS
Twenty-five client-owned WHWTs presented with CIPF and 19 CTRLs were included in the study. PV/PA in either two-dimensional mode (2D) or time-motion mode or both were measured from cineloops in each dog. Dogs were classified according to PV/PA value into non/mild PH (PV/PA measured in 2D ≥ 0.7) or moderate/severe PH (PV/PA < 0.7). Survival data of WHWTs affected with CIPF were extracted from medical record to assess association between presence of PH at diagnosis and outcome. 60 % overall prevalence for moderate/severe PH was estimated in this cohort of WHWTs presented with CIPF vs. 5 % in CTRLS (P = 0.0002). The presence of moderate/severe PH at initial presentation was not associated with survival.
CONCLUSIONS
CONCLUSIONS
Results of the present study confirm a high prevalence of PH at diagnosis in WHWTs affected with CIPF and highlight the utility of PV/PA as a non-invasive surrogate for assessment of PH in this population.
Identifiants
pubmed: 33892687
doi: 10.1186/s12917-021-02879-w
pii: 10.1186/s12917-021-02879-w
pmc: PMC8066956
doi:
Substances chimiques
Vasodilator Agents
0
Sildenafil Citrate
BW9B0ZE037
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
171Subventions
Organisme : Fonds De La Recherche Scientifique - FNRS
ID : This work was done at the Faculty of Veterinary Medicine, University of Liège, Belgium and was supported by a grant from the 'Fonds de la Recherche Scientifique (FNRS)'. The manuscript content (design of the study, data collection, analysis, and interpretation of data) and the opinions expressed in this publication are solely the responsibility of the authors.
Références
J Vet Intern Med. 2020 Jan;34(1):65-73
pubmed: 31816127
J Comp Pathol. 2013 Aug-Oct;149(2-3):303-13
pubmed: 23664319
J Korean Med Sci. 2020 Mar 02;35(8):e48
pubmed: 32103644
Med Sci (Basel). 2018 Aug 30;6(3):
pubmed: 30200249
J Vet Intern Med. 2011 May-Jun;25(3):433-9
pubmed: 21366693
Vet Radiol Ultrasound. 2017 May;58(3):284-294
pubmed: 28229501
J Vet Intern Med. 2010 Jul-Aug;24(4):850-4
pubmed: 20412435
J Vet Cardiol. 2015 Mar;17(1):13-24
pubmed: 25601540
Vet J. 2018 Dec;242:53-58
pubmed: 30503545
Chest. 2006 Mar;129(3):746-52
pubmed: 16537877
Eur Respir J. 2015 Oct;46(4):1113-30
pubmed: 26424523
J Vet Cardiol. 2016 Dec;18(4):326-335
pubmed: 27670068
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620910092
pubmed: 32167024
Chest. 2011 May;139(5):988-993
pubmed: 20864617
Vet Clin North Am Small Anim Pract. 2020 Mar;50(2):431-446
pubmed: 31866093
Vet J. 2019 Sep;251:105347
pubmed: 31492386
J Vet Intern Med. 2015 Nov-Dec;29(6):1502-9
pubmed: 26415640
J Vet Intern Med. 2014 Mar-Apr;28(2):379-85
pubmed: 24417616
Chest. 2005 Dec;128(6 Suppl):616S-617S
pubmed: 16373870
J Am Coll Cardiol. 1985 Oct;6(4):750-6
pubmed: 4031289
J Vet Intern Med. 2006 Jul-Aug;20(4):912-20
pubmed: 16955816
Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):623-41
pubmed: 20610015
Pulm Pharmacol Ther. 2018 Dec;53:6-11
pubmed: 30193867
Vet Radiol Ultrasound. 2017 Jul;58(4):381-388
pubmed: 28335088